These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35507674)

  • 1. JAGGED-NOTCH3 signaling in vascular remodeling in pulmonary arterial hypertension.
    Zhang Y; Hernandez M; Gower J; Winicki N; Morataya X; Alvarez S; Yuan JX; Shyy J; Thistlethwaite PA
    Sci Transl Med; 2022 May; 14(643):eabl5471. PubMed ID: 35507674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOTCH3 and Pulmonary Arterial Hypertension.
    Winicki NM; Puerta C; Besse CE; Zhang Y; Thistlethwaite PA
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
    Wang Y; Dai S; Cheng X; Prado E; Yan L; Hu J; He Q; Lv Y; Lv Y; Du L
    Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):639-651. PubMed ID: 30954415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells Is the Cell of Origin for Occlusive Pulmonary Vascular Lesions.
    Steffes LC; Froistad AA; Andruska A; Boehm M; McGlynn M; Zhang F; Zhang W; Hou D; Tian X; Miquerol L; Nadeau K; Metzger RJ; Spiekerkoetter E; Kumar ME
    Circulation; 2020 Oct; 142(16):1545-1561. PubMed ID: 32794408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Notch signaling by short-term treatment with Jagged-1 enhances store-operated Ca(2+) entry in human pulmonary arterial smooth muscle cells.
    Yamamura H; Yamamura A; Ko EA; Pohl NM; Smith KA; Zeifman A; Powell FL; Thistlethwaite PA; Yuan JX
    Am J Physiol Cell Physiol; 2014 May; 306(9):C871-8. PubMed ID: 24573085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch3 signaling promotes the development of pulmonary arterial hypertension.
    Li X; Zhang X; Leathers R; Makino A; Huang C; Parsa P; Macias J; Yuan JX; Jamieson SW; Thistlethwaite PA
    Nat Med; 2009 Nov; 15(11):1289-97. PubMed ID: 19855400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch3 signalling and vascular remodelling in pulmonary arterial hypertension.
    Morris HE; Neves KB; Montezano AC; MacLean MR; Touyz RM
    Clin Sci (Lond); 2019 Dec; 133(24):2481-2498. PubMed ID: 31868216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
    Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble JAGGED1 inhibits pulmonary hypertension by attenuating notch signaling.
    Xiao Y; Gong D; Wang W
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2733-9. PubMed ID: 24072692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A receptor-specific function for Notch2 in mediating vascular smooth muscle cell growth arrest through cyclin-dependent kinase inhibitor 1B.
    Boucher JM; Harrington A; Rostama B; Lindner V; Liaw L
    Circ Res; 2013 Sep; 113(8):975-85. PubMed ID: 23965337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch3/Hes5 Induces Vascular Dysfunction in Hypoxia-Induced Pulmonary Hypertension Through ER Stress and Redox-Sensitive Pathways.
    Morris HE; Neves KB; Nilsen M; Montezano AC; MacLean MR; Touyz RM
    Hypertension; 2023 Aug; 80(8):1683-1696. PubMed ID: 37254738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.
    Kudryashova TV; Dabral S; Nayakanti S; Ray A; Goncharov DA; Avolio T; Shen Y; Rode A; Pena A; Jiang L; Lin D; Baust J; Bachman TN; Graumann J; Ruppert C; Guenther A; Schmoranzer M; Grobs Y; Eve Lemay S; Tremblay E; Breuils-Bonnet S; Boucherat O; Mora AL; DeLisser H; Zhao J; Zhao Y; Bonnet S; Seeger W; Pullamsetti SS; Goncharova EA
    Circ Res; 2022 Mar; 130(5):760-778. PubMed ID: 35124974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR2 deficiency, dysregulation of Notch signaling, and spontaneous pulmonary arterial hypertension.
    Yu YR; Mao L; Piantadosi CA; Gunn MD
    Am J Respir Cell Mol Biol; 2013 May; 48(5):647-54. PubMed ID: 23492191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation.
    Zhang C; Chen D; Maguire EM; He S; Chen J; An W; Yang M; Afzal TA; Luong LA; Zhang L; Lei H; Wu Q; Xiao Q
    Cardiovasc Res; 2018 Mar; 114(3):443-455. PubMed ID: 29206900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR-Notch3 signaling mediates pulmonary hypertension in hypoxia-exposed neonatal rats independent of changes in autophagy.
    Ivanovska J; Shah S; Wong MJ; Kantores C; Jain A; Post M; Yeganeh B; Jankov RP
    Pediatr Pulmonol; 2017 Nov; 52(11):1443-1454. PubMed ID: 28759157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Long Noncoding RNA LnRPT Is Regulated by PDGF-BB and Modulates the Proliferation of Pulmonary Artery Smooth Muscle Cells.
    Chen J; Guo J; Cui X; Dai Y; Tang Z; Qu J; Raj JU; Hu Q; Gou D
    Am J Respir Cell Mol Biol; 2018 Feb; 58(2):181-193. PubMed ID: 28915060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
    He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
    Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.